Isavuconazole treatment for fungal disease in leukemia patients

At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio Pagliuca, MD from King’s College Hospital, London, UK discusses isavuconazole for fungal disease treatment in leukemia patients. Isavuconazole has less toxicity than voriconazole and shows significant activity over mucormycosis. It has an oral and intravenous (IV) formulation which essential in treatments of sick patients.